ID24818A - Komposisi farmasi yang digunakan pada selaput lendir - Google Patents

Komposisi farmasi yang digunakan pada selaput lendir

Info

Publication number
ID24818A
ID24818A IDW991640A ID991640A ID24818A ID 24818 A ID24818 A ID 24818A ID W991640 A IDW991640 A ID W991640A ID 991640 A ID991640 A ID 991640A ID 24818 A ID24818 A ID 24818A
Authority
ID
Indonesia
Prior art keywords
slimming
pharmaceutical composition
composition used
pharmaceutical
mosm
Prior art date
Application number
IDW991640A
Other languages
English (en)
Indonesian (id)
Inventor
Yoshihisa Nishi
Original Assignee
Teijin Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26450407&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ID24818(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Teijin Ltd filed Critical Teijin Ltd
Publication of ID24818A publication Critical patent/ID24818A/id

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/18—Drugs for disorders of the endocrine system of the parathyroid hormones
    • A61P5/22—Drugs for disorders of the endocrine system of the parathyroid hormones for decreasing, blocking or antagonising the activity of calcitonin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/186—Quaternary ammonium compounds, e.g. benzalkonium chloride or cetrimide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
IDW991640A 1998-04-21 1999-04-21 Komposisi farmasi yang digunakan pada selaput lendir ID24818A (id)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP11088798 1998-04-21
JP11088898 1998-04-21

Publications (1)

Publication Number Publication Date
ID24818A true ID24818A (id) 2000-08-24

Family

ID=26450407

Family Applications (1)

Application Number Title Priority Date Filing Date
IDW991640A ID24818A (id) 1998-04-21 1999-04-21 Komposisi farmasi yang digunakan pada selaput lendir

Country Status (36)

Country Link
US (3) US6939559B1 (fr)
EP (1) EP0998916B1 (fr)
JP (2) JP5142420B2 (fr)
KR (1) KR100686901B1 (fr)
CN (1) CN1304052C (fr)
AT (1) ATE336986T1 (fr)
AU (1) AU757772B2 (fr)
BG (1) BG64919B1 (fr)
BR (1) BRPI9906372B8 (fr)
CA (1) CA2294457C (fr)
CY (1) CY1105771T1 (fr)
CZ (1) CZ298466B6 (fr)
DE (1) DE69932905T2 (fr)
DK (1) DK0998916T3 (fr)
EA (1) EA002967B1 (fr)
EE (1) EE05072B1 (fr)
ES (1) ES2272064T3 (fr)
GE (1) GEP20022669B (fr)
GT (2) GT199900180AA (fr)
HR (1) HRP990402C1 (fr)
HU (1) HU226712B1 (fr)
ID (1) ID24818A (fr)
IL (1) IL133614A (fr)
IS (1) IS2453B (fr)
NO (1) NO328270B1 (fr)
NZ (1) NZ501950A (fr)
PL (1) PL197875B1 (fr)
PT (1) PT998916E (fr)
RS (1) RS49764B (fr)
SI (1) SI0998916T1 (fr)
SK (1) SK286101B6 (fr)
TR (1) TR199903193T1 (fr)
TW (1) TWI243687B (fr)
UA (1) UA77640C2 (fr)
WO (1) WO1999053899A1 (fr)
ZA (1) ZA997727B (fr)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6261836B1 (en) * 1996-10-01 2001-07-17 Geron Corporation Telomerase
AR026073A1 (es) 1999-10-20 2002-12-26 Nycomed Gmbh Composicion farmaceutica acuosa que contiene ciclesonida
AR026072A1 (es) 1999-10-20 2002-12-26 Nycomed Gmbh Composicion farmaceutica que contiene ciclesonida para aplicacion a la mucosa
US7879832B2 (en) * 2002-08-30 2011-02-01 Nycomed Gmbh Use of the combination of ciclesonide and antihistamines for the treatment of allergic rhinitis
AU2003289011A1 (en) * 2002-12-10 2004-06-30 Showa Yakuhin Kako Co., Ltd. Composition for topical anesthesia
DK1572217T3 (da) * 2002-12-12 2008-12-15 Nycomed Gmbh Kombinationsmedikament af R,R-formoterol og ciclesonid
US20050025825A1 (en) 2003-07-31 2005-02-03 Xanodyne Pharmacal, Inc. Tranexamic acid formulations with reduced adverse effects
EP1670482B2 (fr) * 2003-09-16 2022-06-29 Covis Pharma B.V. Utilisation de ciclesonide dans le traitement de maladies respiratoires
PE20050941A1 (es) * 2003-12-16 2005-11-08 Nycomed Gmbh Suspensiones acuosas de ciclesonida para nebulizacion
JP4128521B2 (ja) * 2003-12-19 2008-07-30 信越化学工業株式会社 ゲル状シート及びその製造方法
US20050244495A1 (en) 2004-03-04 2005-11-03 Xanodyne Pharmaceuticals, Inc. Tranexamic acid formulations
US20090215898A1 (en) 2004-03-04 2009-08-27 Xanodyne Pharmaceuticals, Inc. Tranexamic acid formulations
US8022106B2 (en) 2004-03-04 2011-09-20 Ferring B.V. Tranexamic acid formulations
US7947739B2 (en) 2004-03-04 2011-05-24 Ferring B.V. Tranexamic acid formulations
AU2005235384B2 (en) * 2004-04-20 2010-09-09 Covis Pharma B.V. Use of ciclesonide for the treatment of respiratory diseases in a smoking patient
EP1591106B1 (fr) * 2004-04-28 2009-07-22 Shin-Etsu Chemical Co., Ltd. Composition sous forme de film et procédé de préparation
US20070231396A1 (en) * 2006-03-29 2007-10-04 Ray Charles D Medication spray formulation
JP2011514358A (ja) * 2008-03-14 2011-05-06 セファロン、インク． 改良された経粘膜組成物および剤形
EP2445472B1 (fr) * 2009-06-24 2017-12-27 Lipoid GmbH Compositions pour des applications cosmétiques, pharmaceutiques ou diététiques
WO2011135585A2 (fr) 2010-04-28 2011-11-03 Cadila Healthcare Limited Solution pharmaceutique aqueuse de ciclésonide
CA2812299C (fr) 2010-09-23 2020-08-04 Inflammagen, Llc Administration d'inhibiteurs de la protease serine dans l'estomac
PT2661308T (pt) * 2011-01-05 2019-07-31 Prenatal Int Gmbh Composição aquosa hipotónica com teor de cloreto reduzido com ou sem fosfolípido
ES2375784B1 (es) 2011-12-22 2013-01-24 Laboratorios Kin S.A. Gel de ácido tranexámico
KR102397379B1 (ko) 2014-03-25 2022-05-13 리딩 바이오사이언시즈, 인크. 자가소화의 치료용의 조성물
CN104473864B (zh) * 2014-11-25 2017-02-22 陈长潭 一种卡络磺钠半固体制剂及其制备方法
PL3369429T3 (pl) 2015-10-30 2020-06-15 Teijin Pharma Limited Kompozycja farmaceutyczna przeznaczona do podawania na błonę śluzową nosa
BE1025996A9 (fr) 2018-01-19 2020-05-11 Hyloris Dev Sa Solution orale d’acide tranexamique
CN116194147A (zh) * 2020-09-25 2023-05-30 安斯泰来制药株式会社 耳内给药用药物组合物
EP4062919A1 (fr) 2021-03-24 2022-09-28 Prenatal International GmbH Au moins une composition à base de liquide amniotique humain destinée à l'utilisation dans un procédé de nutrition entérale, de supplémentation nutritionnelle entérale et/ou de traitement et/ou d'alimentation des couches peu capillaires

Family Cites Families (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4271143A (en) 1978-01-25 1981-06-02 Alcon Laboratories, Inc. Sustained release ophthalmic drug dosage
CH657779A5 (de) * 1982-10-05 1986-09-30 Sandoz Ag Galenische zusammensetzungen enthaltend calcitonin.
AU572815B2 (en) 1982-12-29 1988-05-19 Armour Pharmaceutical Company Pharmaceutical calcitonin compositions for intranasal application
JPS59163313A (ja) * 1983-03-09 1984-09-14 Teijin Ltd 経鼻投与用ペプチドホルモン類組成物
GB8514090D0 (en) 1985-06-04 1985-07-10 Sandoz Ltd Organic compounds
JPS6034925A (ja) * 1983-08-04 1985-02-22 Mitsubishi Chem Ind Ltd ２−ヒドロキシイソフタルアルデヒド類の製造法
ATE151286T1 (de) 1983-11-14 1997-04-15 Columbia Lab Inc Bioadhäsive mittel
JPS60123426A (ja) * 1983-12-07 1985-07-02 Eisai Co Ltd 経鼻投与用セクレチン製剤
JPS60224616A (ja) 1984-04-24 1985-11-09 Teijin Ltd 経鼻投与用組成物
US5179079A (en) 1986-12-16 1993-01-12 Novo Nordisk A/S Nasal formulation and intranasal administration therewith
NZ222907A (en) 1986-12-16 1990-08-28 Novo Industri As Preparation for intranasal administration containing a phospholipid absorption enhancing system
MY102411A (en) 1986-12-23 1992-06-17 Ciba Geigy Ag Nasal solutions
JPS63303031A (ja) 1987-05-30 1988-12-09 Nippon Piston Ring Co Ltd コンプレッサ用ベ−ン
JPS63303931A (ja) * 1987-06-05 1988-12-12 Sumitomo Pharmaceut Co Ltd 経鼻投与用成長ホルモン放出活性物質製剤
PT88490B (pt) * 1987-09-14 1992-11-30 Novo Nordisk As Processo para a preparacao de composicoes farmaceuticas para libertacao nao-enterica trans-mucosa contendo monossacaridos ou oligossacaridos
US5192535A (en) 1988-02-08 1993-03-09 Insite Vision Incorporated Ophthalmic suspensions
US5188826A (en) 1988-02-08 1993-02-23 Insite Vision Incorporated Topical ophthalmic suspensions
US5776493A (en) 1989-07-14 1998-07-07 Alza Corporation Oral osmotic device for delivery of nystatin with hydrogel driving member
EP0431719B1 (fr) 1989-10-31 1994-11-09 Columbia Laboratories, Inc. Composition pour hydrater le tissu vaginal
US5147654A (en) 1990-07-23 1992-09-15 Alza Corporation Oral osmotic device for delivering nicotine
JPH078806B2 (ja) * 1990-08-16 1995-02-01 旭化成工業株式会社 カルシトニン類含有経鼻投与用乳剤
GB9102579D0 (en) * 1991-01-24 1991-03-27 Glaxo Group Ltd Compositions
GB9103824D0 (en) 1991-02-23 1991-04-10 Fisons Ag Formulation
DE69233116T2 (de) 1991-04-03 2004-08-26 Keimowitz, Rudolph M.D., Wayzata Unterdrückung der thromboxanspiegel durch perkutane verabreichung von aspirin
US5200195A (en) 1991-12-06 1993-04-06 Alza Corporation Process for improving dosage form delivery kinetics
KR100281609B1 (ko) * 1991-12-27 2001-02-15 폴락 돈나 엘. 유효 제제를 포함하는 분산액의 동일 반응계내 생성 및 방출을 조절하는 약물 전달 장치
CN1075081A (zh) * 1992-02-01 1993-08-11 解放军陆军第44医院 复方胶体麻醉剂的配制方法
GB9202519D0 (en) * 1992-02-06 1992-03-25 Glaxo Group Ltd Medicaments
JP3047948B2 (ja) 1992-12-07 2000-06-05 株式会社ツムラ ペプチド類経鼻投与用組成物
US5340572A (en) 1993-02-08 1994-08-23 Insite Vision Incorporated Alkaline ophthalmic suspensions
US5409703A (en) 1993-06-24 1995-04-25 Carrington Laboratories, Inc. Dried hydrogel from hydrophilic-hygroscopic polymer
JP3781792B2 (ja) 1993-12-27 2006-05-31 千寿製薬株式会社 ジフルプレドナート含有点眼用懸濁液剤
JPH07188059A (ja) * 1993-12-28 1995-07-25 Rohto Pharmaceut Co Ltd 歯周病治療剤
RU2102979C1 (ru) 1994-07-18 1998-01-27 Панкрушева Татьяна Александровна Средство для лечения гнойно-воспалительных процессов кожи и слизистых оболочек различной этиологии
WO1997001337A1 (fr) 1995-06-29 1997-01-16 Mcneil-Ppc, Inc. Combinaison d'antihistamines et de steroides a application topique par voie nasale
JP3098401B2 (ja) 1995-07-12 2000-10-16 株式会社エルティーティー研究所 経鼻投与用製剤
JP2791317B2 (ja) 1995-12-26 1998-08-27 株式会社三和化学研究所 多層フィルム製剤
CN1155368C (zh) * 1996-02-27 2004-06-30 帝人株式会社 鼻腔给药的粉剂组合物
JPH09253220A (ja) 1996-03-26 1997-09-30 Kaajiopeeshingu Res Lab:Kk 生体内に植え込み可能なリード
US5976573A (en) * 1996-07-03 1999-11-02 Rorer Pharmaceutical Products Inc. Aqueous-based pharmaceutical composition
RU2111829C1 (ru) 1996-10-09 1998-05-27 Буркин Сергей Павлович Способ непрерывного получения тонкой металлической полосы и машина для его осуществления
US5955097A (en) 1996-10-18 1999-09-21 Virotex Corporation Pharmaceutical preparation applicable to mucosal surfaces and body tissues
TW503113B (en) 1997-01-16 2002-09-21 Senju Pharma Co Aqueous suspension for nasal administration
JP4009355B2 (ja) 1997-10-02 2007-11-14 村樫石灰工業株式会社 芝草地に発生するコケ・藻類の防除用組成物及び防除方法

Also Published As

Publication number Publication date
NO328270B1 (no) 2010-01-18
TWI243687B (en) 2005-11-21
TR199903193T1 (xx) 2000-11-21
BRPI9906372B1 (pt) 2015-09-01
IS2453B (is) 2008-11-15
CZ460499A3 (cs) 2000-05-17
SI0998916T1 (sl) 2007-02-28
DK0998916T3 (da) 2006-12-11
US6939559B1 (en) 2005-09-06
IS5312A (is) 1999-12-20
BG104020A (en) 2000-05-31
ZA997727B (en) 2000-10-12
EP0998916B1 (fr) 2006-08-23
AU757772B2 (en) 2003-03-06
ATE336986T1 (de) 2006-09-15
CY1105771T1 (el) 2011-02-02
YU54499A (sh) 2002-06-19
PL337534A1 (en) 2000-08-28
JP2004099624A (ja) 2004-04-02
PL197875B1 (pl) 2008-05-30
RS49764B (sr) 2008-04-04
KR100686901B1 (ko) 2007-02-26
PT998916E (pt) 2006-12-29
EE05072B1 (et) 2008-10-15
US7235247B2 (en) 2007-06-26
HUP0002512A3 (en) 2001-03-28
ES2272064T3 (es) 2007-04-16
AU3534399A (en) 1999-11-08
EE9900589A (et) 2000-08-15
CN1272784A (zh) 2000-11-08
DE69932905D1 (de) 2006-10-05
US20050181054A1 (en) 2005-08-18
NZ501950A (en) 2003-04-29
DE69932905T2 (de) 2007-04-05
HRP990402A2 (en) 2000-04-30
CA2294457C (fr) 2008-06-17
EA200000060A1 (ru) 2000-08-28
BRPI9906372B8 (pt) 2021-05-25
HU226712B1 (en) 2009-07-28
IL133614A (en) 2004-12-15
EA002967B1 (ru) 2002-12-26
JP5142420B2 (ja) 2013-02-13
EP0998916A4 (fr) 2002-06-19
NO996323D0 (no) 1999-12-20
CN1304052C (zh) 2007-03-14
GT199900180A (es) 2001-12-18
CA2294457A1 (fr) 1999-10-28
US20030008019A1 (en) 2003-01-09
CZ298466B6 (cs) 2007-10-10
BG64919B1 (bg) 2006-09-29
SK182399A3 (en) 2000-07-11
WO1999053899A1 (fr) 1999-10-28
SK286101B6 (sk) 2008-03-05
HRP990402C1 (en) 2008-09-30
HRPK990402B1 (hr) 2001-08-31
EP0998916A1 (fr) 2000-05-10
KR20010014067A (ko) 2001-02-26
UA77640C2 (uk) 2007-01-15
HUP0002512A2 (hu) 2000-12-28
GEP20022669B (en) 2002-04-25
NO996323L (no) 2000-02-18
GT199900180AA (es) 2006-08-29
IL133614A0 (en) 2001-04-30
BR9906372A (pt) 2000-07-11

Similar Documents

Publication Publication Date Title
ID24818A (id) Komposisi farmasi yang digunakan pada selaput lendir
MX10086A (es) Un sistema para la administracion de substancias activas no solubles en agua y procedimiento para su preparacion.
DK1028707T3 (da) Oftalmiske præparater med forlænget frigivelse og indeholdende vandopløselige medikamenter
CO5150154A1 (es) Composicion de sustrato y metodo para usarlo para el secuestro de irritantes de la piel
PT936905E (pt) Pelicula soluvel em agua ou camada soluvel em agua que possuem molhabilidade imediata para aplicacao oral
DK0813424T4 (da) Orale farmaceutiske doseringsformer omfattende en protonpumpeinhibitor og et syreneutraliserende middel eller alginat
ES2155931T3 (es) Forma de administracion de un agente activo de liberacion prolongada en banda.
ATE314054T1 (de) Osmotisches verabreichungssystem für lösliche dosen
IS4146A (is) Lyfjablanda til að gefa dýrum um munn sem inniheldur prótonupumpublokkara
BR0014878A (pt) Composição farmacêutica contendo ciclosonida para aplicação à mucosa
ATE257374T1 (de) Wässriges arzneimittel, das einen in wasser sehr schwerlöslichen aktivbestandteil enthält
PT1014951E (pt) Composicao de revestimento farmaceutica e metodo para a sua utilizacao
IT1291895B1 (it) Preparazione farmaceutica fluida a base di nimesulide per uso orale e rinofaringeo
CR6122A (es) Composicion farmaceutica para ser aplicada a las mucosas
SV1999000181A (es) Composicion farmaceutica para ser aplicada a las mucosas ref. er/cr-203.689
TH56350B (th) ส่วนประกอบทางเภสัชกรรมที่สำหรับใช้กับเยื่อบุ